GO:0003747 | translation release factor activity | 2.20e-06 | 2.15e-02 | 9.347 | 2 | 2 | 2 |
GO:0048511 | rhythmic process | 2.40e-05 | 2.34e-01 | 5.684 | 3 | 5 | 38 |
GO:0042754 | negative regulation of circadian rhythm | 3.29e-05 | 3.21e-01 | 7.762 | 2 | 2 | 6 |
GO:0008380 | RNA splicing | 9.28e-05 | 9.06e-01 | 3.980 | 4 | 21 | 165 |
GO:0006479 | protein methylation | 1.20e-04 | 1.00e+00 | 6.887 | 2 | 2 | 11 |
GO:0003723 | RNA binding | 4.38e-04 | 1.00e+00 | 3.398 | 4 | 22 | 247 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 6.47e-04 | 1.00e+00 | 5.703 | 2 | 3 | 25 |
GO:0042752 | regulation of circadian rhythm | 8.73e-04 | 1.00e+00 | 5.489 | 2 | 5 | 29 |
GO:0006369 | termination of RNA polymerase II transcription | 1.50e-03 | 1.00e+00 | 5.099 | 2 | 5 | 38 |
GO:0014013 | regulation of gliogenesis | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0016149 | translation release factor activity, codon specific | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0045605 | negative regulation of epidermal cell differentiation | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0000939 | condensed chromosome inner kinetochore | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0008609 | alkylglycerone-phosphate synthase activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0008079 | translation termination factor activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0000775 | chromosome, centromeric region | 1.74e-03 | 1.00e+00 | 4.989 | 2 | 6 | 41 |
GO:0001047 | core promoter binding | 1.83e-03 | 1.00e+00 | 4.954 | 2 | 4 | 42 |
GO:0006353 | DNA-templated transcription, termination | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0008611 | ether lipid biosynthetic process | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0007100 | mitotic centrosome separation | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 2 | 2 |
GO:0000785 | chromatin | 3.58e-03 | 1.00e+00 | 4.464 | 2 | 6 | 59 |
GO:0006415 | translational termination | 4.07e-03 | 1.00e+00 | 4.369 | 2 | 2 | 63 |
GO:0008762 | UDP-N-acetylmuramate dehydrogenase activity | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0036123 | histone H3-K9 dimethylation | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0000778 | condensed nuclear chromosome kinetochore | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 2 | 3 |
GO:0070314 | G1 to G0 transition | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0046914 | transition metal ion binding | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:2000001 | regulation of DNA damage checkpoint | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0046976 | histone methyltransferase activity (H3-K27 specific) | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0097452 | GAIT complex | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 4 |
GO:0006449 | regulation of translational termination | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0006333 | chromatin assembly or disassembly | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0036124 | histone H3-K9 trimethylation | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 4 |
GO:0070734 | histone H3-K27 methylation | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0003682 | chromatin binding | 6.14e-03 | 1.00e+00 | 2.954 | 3 | 15 | 252 |
GO:0030529 | ribonucleoprotein complex | 6.81e-03 | 1.00e+00 | 3.989 | 2 | 5 | 82 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.14e-03 | 1.00e+00 | 3.954 | 2 | 5 | 84 |
GO:0004521 | endoribonuclease activity | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0008610 | lipid biosynthetic process | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0006398 | histone mRNA 3'-end processing | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0021695 | cerebellar cortex development | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 2 | 5 |
GO:0071168 | protein localization to chromatin | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 2 | 5 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0042382 | paraspeckles | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 3 | 5 |
GO:0097371 | MDM2/MDM4 family protein binding | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0005654 | nucleoplasm | 8.04e-03 | 1.00e+00 | 1.894 | 5 | 68 | 876 |
GO:0046974 | histone methyltransferase activity (H3-K9 specific) | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 6 |
GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0042054 | histone methyltransferase activity | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0007140 | male meiosis | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0008409 | 5'-3' exonuclease activity | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 2 | 7 |
GO:0007617 | mating behavior | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0000780 | condensed nuclear chromosome, centromeric region | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0045814 | negative regulation of gene expression, epigenetic | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0051382 | kinetochore assembly | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 2 | 7 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 2 | 7 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.15e-02 | 1.00e+00 | 2.623 | 3 | 17 | 317 |
GO:0006397 | mRNA processing | 1.20e-02 | 1.00e+00 | 3.565 | 2 | 12 | 110 |
GO:0006878 | cellular copper ion homeostasis | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0090307 | spindle assembly involved in mitosis | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 8 |
GO:0071949 | FAD binding | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0006379 | mRNA cleavage | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 2 | 9 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 2 | 9 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 1 | 9 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 3 | 9 |
GO:0005515 | protein binding | 1.49e-02 | 1.00e+00 | 0.796 | 11 | 198 | 4124 |
GO:0001967 | suckling behavior | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 4 | 10 |
GO:0007051 | spindle organization | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 10 |
GO:0008143 | poly(A) binding | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 10 |
GO:0008574 | plus-end-directed microtubule motor activity | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 10 |
GO:0000398 | mRNA splicing, via spliceosome | 1.60e-02 | 1.00e+00 | 3.347 | 2 | 15 | 128 |
GO:0008023 | transcription elongation factor complex | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 2 | 11 |
GO:0045120 | pronucleus | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 3 | 11 |
GO:0000132 | establishment of mitotic spindle orientation | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 12 |
GO:0035098 | ESC/E(Z) complex | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 13 |
GO:0035861 | site of double-strand break | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 13 |
GO:0043393 | regulation of protein binding | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 14 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 2 | 15 |
GO:0070932 | histone H3 deacetylation | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 2 | 15 |
GO:0005782 | peroxisomal matrix | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 16 |
GO:0043022 | ribosome binding | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 2 | 17 |
GO:0007052 | mitotic spindle organization | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 3 | 17 |
GO:0006378 | mRNA polyadenylation | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 3 | 18 |
GO:0032320 | positive regulation of Ras GTPase activity | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 2 | 18 |
GO:0006306 | DNA methylation | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 1 | 19 |
GO:0000166 | nucleotide binding | 2.91e-02 | 1.00e+00 | 2.887 | 2 | 13 | 176 |
GO:0044822 | poly(A) RNA binding | 2.93e-02 | 1.00e+00 | 1.704 | 4 | 45 | 799 |
GO:0004842 | ubiquitin-protein transferase activity | 3.00e-02 | 1.00e+00 | 2.863 | 2 | 17 | 179 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.03e-02 | 1.00e+00 | 2.099 | 3 | 29 | 456 |
GO:0034080 | CENP-A containing nucleosome assembly | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 20 |
GO:0071902 | positive regulation of protein serine/threonine kinase activity | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 20 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 20 |
GO:0071346 | cellular response to interferon-gamma | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 20 |
GO:0005720 | nuclear heterochromatin | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 3 | 20 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 2 | 21 |
GO:0016567 | protein ubiquitination | 3.28e-02 | 1.00e+00 | 2.792 | 2 | 14 | 188 |
GO:0005876 | spindle microtubule | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 4 | 24 |
GO:0030901 | midbrain development | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 1 | 25 |
GO:0006281 | DNA repair | 3.78e-02 | 1.00e+00 | 2.681 | 2 | 24 | 203 |
GO:0050885 | neuromuscular process controlling balance | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 1 | 28 |
GO:0006200 | ATP catabolic process | 4.34e-02 | 1.00e+00 | 2.572 | 2 | 13 | 219 |
GO:0008094 | DNA-dependent ATPase activity | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 6 | 29 |
GO:0008026 | ATP-dependent helicase activity | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 3 | 29 |
GO:0005778 | peroxisomal membrane | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 3 | 29 |
GO:0010212 | response to ionizing radiation | 4.51e-02 | 1.00e+00 | 4.440 | 1 | 3 | 30 |
GO:0031490 | chromatin DNA binding | 4.66e-02 | 1.00e+00 | 4.392 | 1 | 1 | 31 |
GO:0005871 | kinesin complex | 4.66e-02 | 1.00e+00 | 4.392 | 1 | 3 | 31 |
GO:0017148 | negative regulation of translation | 4.95e-02 | 1.00e+00 | 4.302 | 1 | 5 | 33 |
GO:0003677 | DNA binding | 5.04e-02 | 1.00e+00 | 1.459 | 4 | 52 | 947 |
GO:0000786 | nucleosome | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 2 | 34 |
GO:0043406 | positive regulation of MAP kinase activity | 5.25e-02 | 1.00e+00 | 4.217 | 1 | 1 | 35 |
GO:0031124 | mRNA 3'-end processing | 5.25e-02 | 1.00e+00 | 4.217 | 1 | 4 | 35 |
GO:0070301 | cellular response to hydrogen peroxide | 5.25e-02 | 1.00e+00 | 4.217 | 1 | 1 | 35 |
GO:0030900 | forebrain development | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 2 | 36 |
GO:0003777 | microtubule motor activity | 5.83e-02 | 1.00e+00 | 4.061 | 1 | 3 | 39 |
GO:0007018 | microtubule-based movement | 5.83e-02 | 1.00e+00 | 4.061 | 1 | 2 | 39 |
GO:0006396 | RNA processing | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 4 | 40 |
GO:0004867 | serine-type endopeptidase inhibitor activity | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 1 | 42 |
GO:0006406 | mRNA export from nucleus | 6.55e-02 | 1.00e+00 | 3.887 | 1 | 7 | 44 |
GO:0002039 | p53 binding | 6.70e-02 | 1.00e+00 | 3.855 | 1 | 4 | 45 |
GO:0008203 | cholesterol metabolic process | 6.99e-02 | 1.00e+00 | 3.792 | 1 | 2 | 47 |
GO:0007626 | locomotory behavior | 6.99e-02 | 1.00e+00 | 3.792 | 1 | 1 | 47 |
GO:0007059 | chromosome segregation | 7.42e-02 | 1.00e+00 | 3.703 | 1 | 4 | 50 |
GO:0005777 | peroxisome | 7.42e-02 | 1.00e+00 | 3.703 | 1 | 2 | 50 |
GO:0006310 | DNA recombination | 7.42e-02 | 1.00e+00 | 3.703 | 1 | 8 | 50 |
GO:0006334 | nucleosome assembly | 7.56e-02 | 1.00e+00 | 3.674 | 1 | 4 | 51 |
GO:0006338 | chromatin remodeling | 8.13e-02 | 1.00e+00 | 3.565 | 1 | 7 | 55 |
GO:0005681 | spliceosomal complex | 8.13e-02 | 1.00e+00 | 3.565 | 1 | 8 | 55 |
GO:0042826 | histone deacetylase binding | 8.55e-02 | 1.00e+00 | 3.489 | 1 | 5 | 58 |
GO:0071013 | catalytic step 2 spliceosome | 8.98e-02 | 1.00e+00 | 3.416 | 1 | 5 | 61 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 9.40e-02 | 1.00e+00 | 3.347 | 1 | 3 | 64 |
GO:0008270 | zinc ion binding | 9.56e-02 | 1.00e+00 | 1.426 | 3 | 39 | 727 |
GO:0000922 | spindle pole | 9.96e-02 | 1.00e+00 | 3.259 | 1 | 4 | 68 |
GO:0006325 | chromatin organization | 1.02e-01 | 1.00e+00 | 3.217 | 1 | 4 | 70 |
GO:0010951 | negative regulation of endopeptidase activity | 1.04e-01 | 1.00e+00 | 3.197 | 1 | 2 | 71 |
GO:0016020 | membrane | 1.04e-01 | 1.00e+00 | 1.109 | 4 | 56 | 1207 |
GO:0016363 | nuclear matrix | 1.07e-01 | 1.00e+00 | 3.157 | 1 | 10 | 73 |
GO:0001649 | osteoblast differentiation | 1.08e-01 | 1.00e+00 | 3.137 | 1 | 5 | 74 |
GO:0071456 | cellular response to hypoxia | 1.11e-01 | 1.00e+00 | 3.099 | 1 | 2 | 76 |
GO:0016605 | PML body | 1.15e-01 | 1.00e+00 | 3.043 | 1 | 5 | 79 |
GO:0042127 | regulation of cell proliferation | 1.16e-01 | 1.00e+00 | 3.025 | 1 | 4 | 80 |
GO:0005819 | spindle | 1.16e-01 | 1.00e+00 | 3.025 | 1 | 6 | 80 |
GO:0044255 | cellular lipid metabolic process | 1.28e-01 | 1.00e+00 | 2.871 | 1 | 2 | 89 |
GO:0008201 | heparin binding | 1.31e-01 | 1.00e+00 | 2.839 | 1 | 4 | 91 |
GO:0016032 | viral process | 1.38e-01 | 1.00e+00 | 1.605 | 2 | 30 | 428 |
GO:0008017 | microtubule binding | 1.39e-01 | 1.00e+00 | 2.747 | 1 | 9 | 97 |
GO:0016887 | ATPase activity | 1.43e-01 | 1.00e+00 | 2.703 | 1 | 5 | 100 |
GO:0000790 | nuclear chromatin | 1.55e-01 | 1.00e+00 | 2.578 | 1 | 9 | 109 |
GO:0003924 | GTPase activity | 1.68e-01 | 1.00e+00 | 2.452 | 1 | 7 | 119 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.76e-01 | 1.00e+00 | 2.381 | 1 | 4 | 125 |
GO:0006184 | GTP catabolic process | 1.82e-01 | 1.00e+00 | 2.324 | 1 | 7 | 130 |
GO:0032403 | protein complex binding | 1.82e-01 | 1.00e+00 | 2.324 | 1 | 5 | 130 |
GO:0005737 | cytoplasm | 1.95e-01 | 1.00e+00 | 0.569 | 6 | 127 | 2633 |
GO:0010467 | gene expression | 1.97e-01 | 1.00e+00 | 1.283 | 2 | 49 | 535 |
GO:0044212 | transcription regulatory region DNA binding | 1.99e-01 | 1.00e+00 | 2.187 | 1 | 13 | 143 |
GO:0005622 | intracellular | 2.01e-01 | 1.00e+00 | 2.167 | 1 | 2 | 145 |
GO:0016874 | ligase activity | 2.02e-01 | 1.00e+00 | 2.157 | 1 | 11 | 146 |
GO:0005874 | microtubule | 2.23e-01 | 1.00e+00 | 1.998 | 1 | 10 | 163 |
GO:0006351 | transcription, DNA-templated | 2.24e-01 | 1.00e+00 | 0.860 | 3 | 47 | 1076 |
GO:0007067 | mitotic nuclear division | 2.26e-01 | 1.00e+00 | 1.980 | 1 | 9 | 165 |
GO:0016071 | mRNA metabolic process | 2.32e-01 | 1.00e+00 | 1.937 | 1 | 10 | 170 |
GO:0006412 | translation | 2.41e-01 | 1.00e+00 | 1.871 | 1 | 12 | 178 |
GO:0008152 | metabolic process | 2.46e-01 | 1.00e+00 | 1.839 | 1 | 6 | 182 |
GO:0016070 | RNA metabolic process | 2.53e-01 | 1.00e+00 | 1.792 | 1 | 10 | 188 |
GO:0005525 | GTP binding | 2.64e-01 | 1.00e+00 | 1.724 | 1 | 12 | 197 |
GO:0030154 | cell differentiation | 2.72e-01 | 1.00e+00 | 1.674 | 1 | 5 | 204 |
GO:0043231 | intracellular membrane-bounded organelle | 2.87e-01 | 1.00e+00 | 1.578 | 1 | 8 | 218 |
GO:0030198 | extracellular matrix organization | 2.91e-01 | 1.00e+00 | 1.559 | 1 | 7 | 221 |
GO:0007186 | G-protein coupled receptor signaling pathway | 3.00e-01 | 1.00e+00 | 1.507 | 1 | 4 | 229 |
GO:0006355 | regulation of transcription, DNA-templated | 3.02e-01 | 1.00e+00 | 0.865 | 2 | 31 | 715 |
GO:0019901 | protein kinase binding | 3.03e-01 | 1.00e+00 | 1.489 | 1 | 8 | 232 |
GO:0006508 | proteolysis | 3.37e-01 | 1.00e+00 | 1.302 | 1 | 11 | 264 |
GO:0046982 | protein heterodimerization activity | 3.38e-01 | 1.00e+00 | 1.297 | 1 | 11 | 265 |
GO:0043565 | sequence-specific DNA binding | 3.49e-01 | 1.00e+00 | 1.243 | 1 | 8 | 275 |
GO:0005634 | nucleus | 3.79e-01 | 1.00e+00 | 0.267 | 6 | 158 | 3246 |
GO:0055114 | oxidation-reduction process | 3.82e-01 | 1.00e+00 | 1.080 | 1 | 9 | 308 |
GO:0000278 | mitotic cell cycle | 3.88e-01 | 1.00e+00 | 1.052 | 1 | 28 | 314 |
GO:0005524 | ATP binding | 4.04e-01 | 1.00e+00 | 0.546 | 2 | 37 | 892 |
GO:0007596 | blood coagulation | 4.12e-01 | 1.00e+00 | 0.941 | 1 | 13 | 339 |
GO:0006366 | transcription from RNA polymerase II promoter | 4.13e-01 | 1.00e+00 | 0.933 | 1 | 23 | 341 |
GO:0044267 | cellular protein metabolic process | 4.24e-01 | 1.00e+00 | 0.887 | 1 | 14 | 352 |
GO:0042802 | identical protein binding | 4.26e-01 | 1.00e+00 | 0.879 | 1 | 15 | 354 |
GO:0005783 | endoplasmic reticulum | 4.50e-01 | 1.00e+00 | 0.773 | 1 | 12 | 381 |
GO:0005829 | cytosol | 5.36e-01 | 1.00e+00 | 0.128 | 3 | 88 | 1787 |
GO:0005730 | nucleolus | 5.74e-01 | 1.00e+00 | 0.097 | 2 | 74 | 1217 |
GO:0005739 | mitochondrion | 6.50e-01 | 1.00e+00 | -0.018 | 1 | 32 | 659 |
GO:0044281 | small molecule metabolic process | 7.43e-01 | 1.00e+00 | -0.375 | 1 | 35 | 844 |
GO:0046872 | metal ion binding | 7.79e-01 | 1.00e+00 | -0.521 | 1 | 24 | 934 |
GO:0016021 | integral component of membrane | 9.22e-01 | 1.00e+00 | -1.229 | 1 | 19 | 1526 |
GO:0070062 | extracellular vesicular exosome | 9.37e-01 | 1.00e+00 | -1.334 | 1 | 51 | 1641 |
GO:0005886 | plasma membrane | 9.52e-01 | 1.00e+00 | -1.454 | 1 | 46 | 1784 |